Holen Sie sich die Stockscreener-App
27.41
0.19%
-0.08
Finanzdaten der Apellis Pharmaceuticals Inc-Aktie (APLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.73%
172.32
|
146.38 | 110.40 | 94.97 | 44.85 |
Operating Expenses
|
1.52%
234.41
|
230.90 | 247.48 | 215.41 | 219.93 |
| Benefits Costs and Expenses |
2.16%
238.58
|
233.53 | 250.40 | 216.81 | 222.34 |
| Costs And Expenses |
2.16%
238.58
|
233.53 | 250.40 | 216.81 | 222.34 |
| Operating Income/Loss |
26.54%
-62.09
|
-84.52 | -137.08 | -120.44 | -175.08 |
| Income/Loss From Continuing Operations Before Tax |
23.98%
-66.25
|
-87.15 | -140.00 | -121.84 | -177.50 |
| Income Tax Expense/Benefit |
88.05%
0.17
|
1.423 | 0.233 | 0.194 | 0.282 |
| Income/Loss From Continuing Operations After Tax |
25.01%
-66.42
|
-88.58 | -140.24 | -122.04 | -177.78 |
|
Net Income/Loss
|
25.01%
-66.42
|
-88.58 | -140.24 | -122.04 | -177.78 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.90%
0.123
|
118.56 | 0.1203 | 0.1193 | 0.1139 |
| Diluted Average Shares |
99.90%
0.123
|
118.56 | 0.1203 | 0.1193 | 0.1139 |
| Basic Earnings Per Share |
25.00%
-0.54
|
-0.72 | -1.17 | -1.02 | -1.56 |
| Diluted Earnings Per Share |
25.00%
-0.54
|
-0.72 | -1.17 | -1.02 | -1.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):